Article

Novel use of abatacept and ruxolitinib as salvage therapy in steroid-refractory immune checkpoint blockade-induced myocarditis with myasthenia and myositis overlap syndrome

European Journal of Cancer
DOI: 10.1016/j.ejca.2024.114027
4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Byer, S. H., Stewart, C., Mansour, S., & Grewal, U. S. (2024, May 1). Novel use of abatacept and ruxolitinib as salvage therapy in steroid-refractory immune checkpoint blockade-induced myocarditis with myasthenia and myositis overlap syndrome. European Journal of Cancer. Elsevier Ltd. https://doi.org/10.1016/j.ejca.2024.114027

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free